Human Fab (IgG1k) phage display libraries were constructed from bone marrow RNA from 2 donors who recovered from infection with Ebola (EBO) virus during the 1995 outbreak in Kikwit, Democratic Republic of the Congo. The libraries were initially panned against a radiation-inactivated EBO virus -infected Vero cell lysate, but only weak binders were identified. In contrast, panning against secreted EBO glycoprotein (SGP) resulted in Fabs showing very strong reactivity with SGP in ELISA. These Fabs also reacted with a virion membrane preparation. The Fabs were strongly positive in IFAs with cells infected with EBO (subtype Zaire) virus but negative with uninfected cells, with a characteristic punctate staining pattern in the cytoplasm. The Fabs showed weak or no reactivity with the virus cell lysate although donor serum did react. The Fabs are now being characterized in structural and functional terms. Major interest will focus on the ability of antibodies to neutralize EBO virus and, later, to protect animals against infection.
Filoviruses are nonsegmented, negative-strand RNA viruses virus. The proteins are VP40 and VP24, putative matrix proteins; NP, the primary structural protein associated with nucleothat have caused sporadic episodes of severe hemorrhagic discapsid; L-protein, an RNA-dependent RNA polymerase; VP35, ease in human and nonhuman primates [1] . Epidemics in huwhich has an unknown function; and GP, a type I transmemmans have been characterized by a 25% -90% case-fatality brane glycoprotein, which is the sole filovirus structural glycorate, depending on the strain transmitted. Two different groups protein. GP forms spikes on the surface of the virion composed of viruses have been identified within the Filoviridae: Marburg of a GP homotrimer (on MBG and presumably also on EBO) (MBG) virus, with no known subtypes, and Ebola (EBO) virus, [11] . which has 4 subtypes that are provisionally referred to by their
The GP gene of EBO is unusual in that it encodes two initial geographic site of recognition (Zaire [EBO-Z], Sudan, proteins, one of which is expressed through transcriptional editReston, and Côte d'Ivoire) [2 -4] . Serologic testing has reing. The primary gene product is a short, nonstructural, secreted vealed no cross-reactivity between MBG and EBO viruses. The glycoprotein (SGP). The secondary gene product (GP) is the subtypes of EBO have common as well as unique antigenic structural glycoprotein, which is expressed after a single adenodeterminants [1, 5, 6] . Infection with EBO-Z has typically been sine nucleotide is inserted, connecting two reading frames in associated with the highest case fatality rates [1, 7] . the genomic RNA template, although translational frame-shiftThe genomes of MBG and EBO-Z viruses have been anaing is also thought to be a mechanism of expression of this lyzed in the most detail [8 -10] . These analyses indicate comform of GP. The SGP contains the same Ç300 N-terminal mon mechanisms of transcription and replication of genomic amino acids as the GP, but the C-terminus (Ç70 amino acids) RNA with Rhabdoviridiae and Paramyxoviridae. Seven genes is unique. producing eight identified proteins have been identified in EBO a-interferon and existing antiviral drugs are ineffective against filoviruses. Convalescent human sera, although clearly having serum antibodies reactive with EBO virus, generally possess marginal neutralizing ability for the virus in vitro and Informed consent was obtained from all donors. The study followed human no beneficial effect when administered to infected persons [1] . reminders of the dangers of unpreparedness in the face of according to the manufacturer's recommended conditions. The emerging virus threats. Small changes in these viruses affecting IgG1 Fd region and whole k light chains were then amplified by transmissibility or virulence could lead to devastating epidempolymerase chain reaction (PCR) as described previously [22] .
ics. Although aerosol transmission of EBO has not been docuHeavy-chain Fd and light-chain PCR products were gel-purified, electroeluted, and reamplified using extension primers with a 5 mented in human outbreaks to date, aerosol transmission has poly (GA) tail to increase restriction enzyme digestion and subsebeen implicated for both MBG and EBO viruses among nonhuquent cloning efficiency [23] .
man primates [16 -20] . Panels of human antibodies to these IgG1k libraries were constructed in the phage display vector viruses can be a very valuable resource, both in terms of current morpholino)propanesulfonic acid per liter (pH 7.0). The carbenicillin was increased to 50 mg/mL, and after being allowed to grow for 1 h, phage particle assembly was initiated by adding VCS-
Materials and Methods
M13 helper phage (5 1 10 11 pfu). After an additional 2-h culture, RNA isolation. Bone marrow was obtained from 2 Kikwit pakanamycin was added at 70 mg/mL, and the culture was grown tients (donor K and donor L) who recovered from EBO-Z infection.
overnight at 30ЊC. To recover phage from the cultures, bacteria Donor K became ill on 4 May 1995 and was hospitalized on 7 were removed by centrifugation at 4000 g, and then phage was May. Donor L became ill on 14 April 1995 and was hospitalized precipitated from the supernatant by the addition of 4% polyethylon 19 April. Bone marrow from both donors was obtained on 22 ene glycol and 0.5 M NaCl followed by incubation on ice for 30 August. Serum samples were concomitantly obtained from each min. After centrifugation, phage pellets were resuspended in 500 donor.
mL of PBS-1% bovine serum albumin and centrifuged for 5 min Donor K's bone marrow was lysed by vigorous mixing with in a microcentrifuge to pellet bacterial debris. EBO-Z and contained SGP (coated 1:10 in PBS); and a gammaDonor L's bone marrow was immediately frozen after aspiration irradiated virion membrane fraction (coated 1:100 in PBS). and shipped to the United States on dry ice. The bone marrow For the last preparation, crude virion pellets of the 1976 and was thawed directly into denaturant solution in a laminar flow 1995 strains of EBO-Z were pooled and treated with 0.02% Triton biosafety cabinet, following the usual precautions. RNA was pre-X-100 for several minutes, and then the sample was diluted 2.5 pared by adding 1 mL of 2 M sodium acetate (pH 4.0) to each 10 times and the insoluble fraction was pelleted. The supernatant was mL of lysate. The samples were extracted with 10 mL of acidic then dialyzed against PBS. After being coated, the plates were phenol (saturated with 0.1 M citrate buffer [pH 4.3; Sigma] and 2 washed and blocked with 4% nonfat dry milk (Bio-Rad, Hercules, mL of chloroform-isoamyl alcohol [24:1]). After a 15-min incuba-CA) for 1 h at 37ЊC. The milk solution was shaken out, and phage tion on ice, the samples were spun at 10,000 g for 20 min at 4ЊC.
solution was added to each well and incubated for 2 h at 37ЊC on RNA was precipitated from the supernatant by the addition of 40 a rocker platform. The phage solution was removed, and the wells mg of glycogen (Boehringer Mannheim, Indianapolis) and 15 mL were washed. Bound phage was eluted with glycine buffer (pH 2.2) and neutralized with 2 M Tris base. Eluted phage was reampliof 2-propanol (Sigma) followed by overnight incubation at 020ЊC Figure 1 . Reactivity of human anti-Ebola Fabs with Ebola antigen preparations determined by ELISA. Ovalbumin was included as control antigen. Reactivity of serum from donor K is shown.
fied for the next round of panning, as previously described [24] .
at 37ЊC for 1 h. The milk was discarded, and undiluted bacterial supernatants were added to the wells and incubated for 1 h at The libraries were panned for four consecutive rounds with increasing stringency in the first three washes (11, 51, 101, and 37ЊC. The plates were washed, and bound Fab was detected with alkaline phosphatase-coupled goat anti-human F(ab) 2 antibody 101 wash steps, each consisting of a 5 min incubation and vigorous pipetting). Phagemid DNA, which had been isolated after the (Pierce). For the IFA, microscope slides were prepared with acetone-fixed last round of panning, was digested with NheI and SpeI and relegated to excise the cpIII gene and obtain plasmids producing solugamma irradiated EBO-Z-infected Vero E6 cells or uninfected cells. The cells were blocked for 1 h with 4% nonfat dry milk and 10% ble Fabs.
Analysis of soluble Fab fragments. Fab cultures were grown normal goat serum (NGS) (Jackson, West Grove, PA) in PBS. The milk was discarded and replaced with bacterial supernatant or convafrom single colonies overnight at 30ЊC, and bacterial lysate was obtained through freeze-thaw cycles [24] . Bacterial supernatants lescent serum diluted in PBS-1% NGS and incubated overnight at 4ЊC in a moist chamber. The slides were washed three times with were tested by ELISA and IFA.
For the ELISA, the three antigens used for panning and control PBS for 45 min and incubated for 1 h at 37ЊC with a 1:200 dilution of FITC-coupled goat IgG F(ab) 2 -anti-human F(ab) 2 (Jackson) in antigen ovalbumin (4 mg/mL; Pierce, Rockford, IL) were coated to microtiter wells (overnight at 4ЊC). The plates were washed PBS-1% NGS. After 3 washes with PBS as above, the cells were examined by immunofluorescence. with PBS-0.05% Tween 20 and blocked with 4% nonfat dry milk In conclusion, we have described the preparation of antibody ing kit (ABI) as described previously [25] .
phage display libraries from bone marrow of patients who recovered from infection with EBO-Z as well as the isolation of the first human monoclonal antibodies to this pathogen.
Results and Discussion
Library construction. IgG1k libraries were constructed
